The Institute of Natural Products and Agrobiology conducts an intense research in response to the growing scientific demand. Our main objective is to achieve researching at the IPNA yields benefits for economic, cultural and social welfare.
From the Knowledge Transfer Office we try to open a channel of communication among our research communities, which provides results and scientific advances, and companies able to implement solutions and discoveries to the needs or develop of new products and services.
The Institute provides various services for scientific and technological support to any business that can benefit from the capabilities and resources of the center and are summarized as follows:
Technology Support Services: analysis, testing, validation, etc.
Technological problems solving and new products / services development under R&D contract.
Vaccine to treat and prevent prostate cancer
The CSIC has developed an immunotherapy approach based on a bifunctional compound for the treatment and prevention of prostate cancer, the second most common cancer worldwide for men and fifth most common cancer overall. Industrial partners from the pharmaceutical industry are being sought, for collaboration through a patent licence agreement.
Biopolymer-based adhesive for different types of surfaces
The CSIC has developed an eco-friendly adhesive with properties and characteristics unique in the industry. In addition to high mechanical and chemical resistance, its ease of application and low production cost make this an ideal adhesive for a wide range of surfaces. We are seeking companies interested in acquiring the patent licence, to undertake the development of new adhesive products.
Vitamin derivative for the control of the Huanglongbing psyllids vectors (HLB)
The Spanish Research Council (CSIC) has developed a compound for the biostimulation of the natural defense mechanisms of the plants. In particular, the compound has been particularly effective in controlling the insects of the Trioza erytreae and Diapharoina citri, vector of the bacterium (Candidatus Liberibacter) that causes the Huanglongbing disease (HLB), considered the most destructive disease that currently affects crops citrus worldwide. Partners are being sought to exploit the existing know-how.
Formulations for improving agricultural production in drought conditions
CSIC has developed a series of formulations based on organic molecules that improve the tolerance of plants under severe conditions of drought and high salinity of the environment, main problem in agricultural production, resulting in large economic losses. The origin of this problem lies mainly in the desertification of the environment due to climate change or irrigation with low quality water with high salt content.
The fundamental aim of the Spanish National Research Council (CSIC), and therefore of the IPNA in Tenerife, is to develop and promote research directed towards scientific and technological progress. For this purpose, it is open to collaboration with both public and private entities, national and international.
According to its Statute (Article 4), its mission is the promotion, coordination, development and dissemination of scientific and technological research. This has a multidisciplinary nature, to contribute to the advancement of knowledge and economic, social and cultural development, as well as the training of personnel and advice to other entities regarding its area of competence. Our final goal is for these collaborations to become fruitful knowledge transfer initiatives.
Over the years, the IPNA has fostered a wide range of research projects carried out in collaboration with different types of entities, both public and private, including start-ups, small and medium-sized businesses, large companies or public administrations. These joint projects include research activities financed by both public and private funds, sub-contracted research, consultancy or personnel exchange programmes.
Examples of collaboration projects:
Cabildo de Tenerife - Knowledge Transfer Plan
The Cabildo Insular de Tenerife supports the IPNA's research work with the creation of a Knowledge Transfer Plan specifically designed for the centre. This initiative is part of the Tenerife 2030 strategy and is financed by the Canary Islands Development Fund (FDCAN) within the Strategic Framework for Island Development (MEDI).
The main objective of this Plan is to bring the scientific capacities as well as the technological achievements developed in the centre closer to all socio-economic sectors, mainly on a regional scale (companies, universities, public administration, etc.), in order to transform research into social and economic welfare.
Biotic and Abiotic Stress Tolerance Inducers
The Research Group on Chemical Activators of Plant Defences, directed by Dr. Andrés Borges, collaborates intensively with the company Manvert, S.L. Together, they development of new formulations based on natural products capable of inducing resistance to (biotic) pathogens and pests, as well as to abiotic environmental stress factors such as salinity and drought, always in a sustainable and environmentally friendly manner.
Cabildo de La Palma: Knowledge Transfer Plan
La Palma Island Council (Cabildo Insular de La Palma) and the Spanish National Research Council (CSIC), through the Institute for Natural Products and Agrobiology (IPNA), have maintained close collaboration in scientific research and technological development over the years.
Among other activities, collaboration areas between the Cabildo and the CSIC include specific studies, research and development projects, advice and training of technical personnel in areas of common interest, as well as activities for the social promotion of research and technological development.
Orfan Biotech is a company dedicated to the research and development of new compounds based on small molecules for the treatment of rare diseases.
Currently, the company is focusing on the preclinical study of a new set of compounds that prevent the deposition of calcium oxalate crystals in organs, as a prospective treatment for primary hyperoxaluria type 1 (PH1) known as ‘orphan disease’.